Evidence map›Paper›PMID 39161065›Full record

ArticlePhysiological reports2024

Alterations of plasma metabolomes and their correlations with immunogenicity in maintenance hemodialysis patients receiving different COVID-19 vaccine regimens.

Phoom Narongkiatikhun, Chanisa Thonusin, Sirawit Sriwichaiin, Wichwara Nawara, Kanda Fanhchaksai, Nuttanun Wongsarikan, Sirinart Kumfu, Nipon Chattipakorn, Siriporn C Chattipakorn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physiological reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Phoom NarongkiatikhunDivision of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chanisa ThonusinCardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sirawit SriwichaiinCardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Wichwara NawaraCardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kanda FanhchaksaiDivision of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nuttanun WongsarikanDepartment of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Sirinart KumfuCardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Nipon ChattipakornCardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Siriporn C ChattipakornCardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-1677-7052

Funding

Chiang Mai University FundamentalFund2024(SK)National Research Council of Thailand N42A650303National Research Council of Thailand N42A660301National Research Council of Thaliand N42A650303Thailand Research and Innovation Program RGN 64-059Thailand Science Research and Innovation Program RGNS 64-059
6 · The paper itself

Abstract

Maintenance hemodialysis (MHD) patients exhibit compromised immune responses, leading to lower immunogenicity to the COVID-19 vaccine than the general population. The metabolomic factors influencing COVID-19 vaccine response in MHD patients remain elusive. A cross-sectional study was conducted with 30 MHD patients, divided into three vaccine regimen groups (N= 10 per group): homologous CoronaVac

Indexed as

COVID-19COVID-19 VaccinesMetabolomeRenal DialysisAdultAgedAntibodies, NeutralizingAntibodies, ViralChAdOx1 nCoV-19Cross-Sectional StudiesFemaleHumansImmunogenicity, VaccineMaleMiddle AgedSARS-CoV-2Antibodies, NeutralizingAntibodies, ViralChAdOx1 nCoV-19COVID-19 VaccinesCOVID‐19hemodialysisplasma metabolomesvaccinevaccine immunogenicity

Identifiers

PMID39161065
PMCPMC11333532

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.